SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]:
SEC Accession No. 0000950170-23-009053
Filing Date
2023-03-22
Accepted
2023-03-22 08:40:38
Documents
103
Period of Report
2022-12-31

Document Format Files

Seq Description Document Type Size
1 10-K inzy-20221231.htm   iXBRL 10-K 3587969
2 EX-21.1 inzy-ex21_1.htm EX-21 8991
3 EX-23.1 inzy-ex23_1.htm EX-23 12479
4 EX-31.1 inzy-ex31_1.htm EX-31 18611
5 EX-31.2 inzy-ex31_2.htm EX-31 18800
6 EX-32.1 inzy-ex32_1.htm EX-32 10771
7 EX-32.2 inzy-ex32_2.htm EX-32 10978
8 GRAPHIC img186495686_0.jpg GRAPHIC 133424
9 GRAPHIC img186495686_1.jpg GRAPHIC 148487
10 GRAPHIC img186495686_2.jpg GRAPHIC 216344
11 GRAPHIC img186495686_3.jpg GRAPHIC 187543
12 GRAPHIC img186495686_4.jpg GRAPHIC 77312
13 GRAPHIC img186495686_5.jpg GRAPHIC 164995
14 GRAPHIC img186495686_6.jpg GRAPHIC 61928
15 GRAPHIC img186495686_7.jpg GRAPHIC 66801
16 GRAPHIC img186495686_8.jpg GRAPHIC 73275
17 GRAPHIC img186495686_9.jpg GRAPHIC 79398
18 GRAPHIC img186495686_10.jpg GRAPHIC 24756
19 GRAPHIC img186495686_11.jpg GRAPHIC 46178
20 GRAPHIC img186495686_12.jpg GRAPHIC 70127
21 GRAPHIC img186495686_13.jpg GRAPHIC 11604
22 GRAPHIC img186495686_14.jpg GRAPHIC 104921
23 GRAPHIC img186495686_15.jpg GRAPHIC 48757
24 GRAPHIC img186495686_16.jpg GRAPHIC 17684
25 GRAPHIC img186495686_17.jpg GRAPHIC 89254
26 GRAPHIC img186495686_18.jpg GRAPHIC 45530
27 GRAPHIC img186495686_19.jpg GRAPHIC 30426
28 GRAPHIC img186495686_20.jpg GRAPHIC 12780
29 GRAPHIC img186495686_21.jpg GRAPHIC 73172
30 GRAPHIC img186495686_22.jpg GRAPHIC 19122
31 GRAPHIC img186495686_23.jpg GRAPHIC 30326
32 GRAPHIC img186495686_24.jpg GRAPHIC 89016
33 GRAPHIC img186495686_25.jpg GRAPHIC 82434
  Complete submission text file 0000950170-23-009053.txt   16432655

Data Files

Seq Description Document Type Size
34 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE DOCUMENT inzy-20221231_def.xml EX-101.DEF 253864
35 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT inzy-20221231_pre.xml EX-101.PRE 424399
36 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT inzy-20221231.xsd EX-101.SCH 56887
37 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE DOCUMENT inzy-20221231_cal.xml EX-101.CAL 53414
38 XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT inzy-20221231_lab.xml EX-101.LAB 573042
97 EXTRACTED XBRL INSTANCE DOCUMENT inzy-20221231_htm.xml XML 1899700
Mailing Address 321 SUMMER STREET SUITE 400 BOSTON MA 02210
Business Address 321 SUMMER STREET SUITE 400 BOSTON MA 02210 857-330-4340
Inozyme Pharma, Inc. (Filer) CIK: 0001693011 (see all company filings)

IRS No.: 475129768 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-K | Act: 34 | File No.: 001-39397 | Film No.: 23751525
SIC: 2834 Pharmaceutical Preparations